Araştırma Makalesi

Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line

Cilt: 5 Sayı: 3 18 Eylül 2023
PDF İndir
EN

Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line

Öz

Aim: In this study, it was aimed to determine the total phenolic content, flavonoid content, and antioxidant activity of Castanea sativa Mill. (chestnut) leaf extract and their anti-proliferative effect on MCF 7 cell line. Materials and Methods: It determined antioxidant capacities by using DPPH assay, total phenolic content by using Folin-Ciocaltaeu method and Total flavonoid content by aluminum chloride colorimetric method in the ethanolic extracts of Chesnut leaf. In addition, the anti-proliferative effect of chestnut leaf extract was determined by XTT method in MCF7 breast cell line. The leaf extract used was applied at different concentrations for 24 hours, 48 hours and 72 hours and the results were evaluated with the Graphpad Prism software program. Results: In this study, it was revealed that the total phenolic contents of ethanolic extracts of chestnut leaf 58,22 mg GAE/g. Total flavonoid content was 64,62 mg QE/g. The DPPH activity of the leaf extract of chestnut was 80.06%. Moreover, findings showed that Chestnut leaf extract had cytotoxic effect against breast cancer cells depends on concentration and time. The 24h, 48h and 72h most effective IC50 dose were 100.1 μL ,193 μL 15.23 μL, respectively. Conclusion: Chestnut has potential antiproliferative and antioxidant activities in conjunction with its high phenolic and flavonoid content on the MCF-7 cell line. However, more studies are needed.

Anahtar Kelimeler

Kaynakça

  1. 1. World Health Organization. WHO report on cancer: setting priorities, investing wisely and providing care for all. 2020, p. 149.
  2. 2. Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer ıncidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749-68.
  3. 3. Steichen, SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur. J. Pharm. Sci. 2013;48:416–27.
  4. 4. Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020;20:417-36.
  5. 5. Liu YP, Zheng CC, Huang YN, et al. Molecular mechanisms of chemo-and radiotherapy resistance and the potential implications for cancer treatment. MedComm. 2021; 2:315-40.
  6. 6. Kayedi MH, Haghdoost AA, Salehnia A, et al. Evaluation of repellency effect of essential oils of Satureja khuzestanica (Carvacrol), Myrtus communis (Myrtle), Lavendula officinalis and Salvia sclarea using Standard WHO Repellency Tests. J. Arthropod Borne Dis. 2014;8:60-8.
  7. 7. Hamburger M, Hostettmann K. 7. Bioactivity in plants: the link between phytochemistry and medicine. Phytochem. 1991;30:3864-74.
  8. 8. Dar RA, Shahnawaz M, Qazi PH. General overview of medicinal plants: A review. J Phytopharmacol. 2017;6:349-51.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Erken Görünüm Tarihi

12 Temmuz 2023

Yayımlanma Tarihi

18 Eylül 2023

Gönderilme Tarihi

4 Nisan 2023

Kabul Tarihi

29 Mayıs 2023

Yayımlandığı Sayı

Yıl 2023 Cilt: 5 Sayı: 3

Kaynak Göster

APA
Beyazyüz, F., Gülbahçe Mutlu, E., Alpa, S., Erbayram, F. Z., Türkoğlu, F. N., & Kulaç, Ş. (2023). Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line. Medical Records, 5(3), 472-7. https://doi.org/10.37990/medr.1276955
AMA
1.Beyazyüz F, Gülbahçe Mutlu E, Alpa S, Erbayram FZ, Türkoğlu FN, Kulaç Ş. Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line. Med Records. 2023;5(3):472-7. doi:10.37990/medr.1276955
Chicago
Beyazyüz, Fadime, Elif Gülbahçe Mutlu, Serife Alpa, Fatma Zehra Erbayram, Fatma Nur Türkoğlu, ve Şemsettin Kulaç. 2023. “Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line”. Medical Records 5 (3): 472-7. https://doi.org/10.37990/medr.1276955.
EndNote
Beyazyüz F, Gülbahçe Mutlu E, Alpa S, Erbayram FZ, Türkoğlu FN, Kulaç Ş (01 Eylül 2023) Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line. Medical Records 5 3 472–7.
IEEE
[1]F. Beyazyüz, E. Gülbahçe Mutlu, S. Alpa, F. Z. Erbayram, F. N. Türkoğlu, ve Ş. Kulaç, “Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line”, Med Records, c. 5, sy 3, ss. 472–7, Eyl. 2023, doi: 10.37990/medr.1276955.
ISNAD
Beyazyüz, Fadime - Gülbahçe Mutlu, Elif - Alpa, Serife - Erbayram, Fatma Zehra - Türkoğlu, Fatma Nur - Kulaç, Şemsettin. “Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line”. Medical Records 5/3 (01 Eylül 2023): 472-7. https://doi.org/10.37990/medr.1276955.
JAMA
1.Beyazyüz F, Gülbahçe Mutlu E, Alpa S, Erbayram FZ, Türkoğlu FN, Kulaç Ş. Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line. Med Records. 2023;5:472–7.
MLA
Beyazyüz, Fadime, vd. “Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line”. Medical Records, c. 5, sy 3, Eylül 2023, ss. 472-7, doi:10.37990/medr.1276955.
Vancouver
1.Fadime Beyazyüz, Elif Gülbahçe Mutlu, Serife Alpa, Fatma Zehra Erbayram, Fatma Nur Türkoğlu, Şemsettin Kulaç. Determination of Antioxidant and Anticancer Activities of C. Sativa Leaf Extracts on MCF7 Human Breast Cancer Cell Line. Med Records. 01 Eylül 2023;5(3):472-7. doi:10.37990/medr.1276955

Cited By